BMC MED 润色咨询

BMC Medicine

出版年份:2003 年文章数:2781 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:1.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-07-30 ms5000001801198305 来自上海

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修)

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-03-04 ms3000001077948666 来自北京

    1-6 投稿
    1-6 editor assigned
    1-11 reviewers assigned
    2-27 under review
    3-1 reviewers assigned
    3-3 under review

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-04-28 ms3000001172034074 来自湖南省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:拒稿挺干脆的

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2023-09-01 ms5000000540226119 来自江苏省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:阿尔茨海默;脑血管病
    经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-03-27 Relivenus 来自安徽省

    reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2023-11-02 ms3000000083679726 来自青海省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:内科;内分泌
    经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月
    今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。

    总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。

    8

    展开8条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2023-06-18 ms1000000442305232 来自新疆

    审稿速度:6.0 | 投稿命中率:75.0
    经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。

    12

    展开12条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-03-27 osmataku 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:脑血管病
    经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2024-03-07 ms3000001406640384 来自湖北省

    偏重的研究方向:流行病学
    经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)
    另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T)

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2217482, encodeId=8567221e4823d, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月投稿,7月接收。3个审稿人,修了3次(因为半路又回来一个审稿人,跟之前的意见不合,又重新大修), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f13b8167733, createdName=ms5000001801198305, createdTime=Tue Jul 30 09:48:06 CST 2024, time=2024-07-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191029, encodeId=68a12191029fd, content=1-6 投稿<br>1-6 editor assigned<br>1-11 reviewers assigned<br>2-27 under review<br>3-1 reviewers assigned<br>3-3 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7a18637611, createdName=ms3000001077948666, createdTime=Mon Mar 04 19:27:41 CST 2024, time=2024-03-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2200944, encodeId=4a382200944df, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:拒稿挺干脆的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96539239417, createdName=ms3000001172034074, createdTime=Sun Apr 28 21:31:39 CST 2024, time=2024-04-28, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2155573, encodeId=79fc21555e3e3, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:阿尔茨海默;脑血管病<br>经验分享:BMC Medicine,BMC家旗下相当好的综合医学期刊,当前(指截止2023.9.1) Impact Factor 9.3,但是审稿速度相当堪忧,官网提供的宣称指出“62 days submission to first editorial decision for all manuscripts (Median),130 days submission to accept (Median)”,即中位数62天才能给出第一次送外审后的编辑部决定,中位数130天才能正式接受发表。但实际上其官网的Transparent Peer Review指出大部分稿件往往需要花上近半年的时间才可以最终发表,并且审稿人中途退出以及更换审稿人的现象较为常见,审稿人以及编辑部的意见也往往较为犀利,Submission多需要经过三四次的Revision才会被最终Accept,综合评价为投递需要经过慎重考虑,Desk Reject那便还好,如果你的文章时效性较强,那么一旦被送出外审后进入漫长的Review恐会影响你文章后续的时效性价值,甚至有被其他课题研究人员于某些****杂志抢发类似文章的风险, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230901/2a7d5f18f2da4f88a75e8228cba79e49/fee30ca09b6941eaa15a81b9056f0a58.jpg, createdBy=fa0a8354937, createdName=ms5000000540226119, createdTime=Fri Sep 01 09:54:24 CST 2023, time=2023-09-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2195753, encodeId=75022195e531b, content=reviewers assigned两个多月了,日期一直在更新,请问这种情况大概还要持续多久T T, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=eb355507716, createdName=Relivenus, createdTime=Wed Mar 27 22:23:29 CST 2024, time=2024-03-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2166267, encodeId=7dca216626e71, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:内科;内分泌<br>经验分享:首先BMC是系列的速度都是很慢的从官网上可以看见所有稿件的审稿流程少则4 5个月多则9-10个月<br>今年2月20号投了BMC medicine,初审忘了多久,6.30给了修改意见。找了4个审稿人30多条意见,客观的说意见都非常专业,但都可以解决。有些不合适的意见也合理的驳回了。7.25修回。编辑可能觉得太顺利了8.14找了reviewer #5。大大小小给了10几条意见。9.6修回,然后操蛋的来了应该是审稿人粘贴错了把别的稿件的意见粘错到我的审稿意见上了。立马发邮件询问。三天后编辑来了邮件承认是工作失误,让我重新提交。然后10.7给了reviewer #5第二次的意见(前面4个都认同了修改),认为有一个意见回复的不够清楚,实际我是把他提的两条意见一起回复了,没办法又拆开重新回复了一下,10.20编辑让小修,就是问有没有推号可以添加,改下格式,作者贡献那些小东西。10.22修回,10.25接收,10.31让交版面费3790美金。<br><br>总的来说,除了审稿非常慢其他的都还好,意见都很专业。看官网的Peer review半路增加审稿人好像是常态,一般都会修改4 5次。<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe715530883, createdName=ms3000000083679726, createdTime=Thu Nov 02 14:02:03 CST 2023, time=2023-11-02, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2143565, encodeId=b73b2143565c1, content=审稿速度:6.0 | 投稿命中率:75.0<br>经验分享:投了一篇横断面调查,一修只有三五条小小的意见,二修回来就是格式修改了,今天刚退修回去,不知道后续还会不会出问题了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=29a35455367, createdName=ms1000000442305232, createdTime=Sun Jun 18 23:27:20 CST 2023, time=2023-06-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2195629, encodeId=78562195629d5, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:脑血管病<br>经验分享:2024 new impact factor 7.5 review 很快过审 一区高性价比, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Mar 27 11:05:29 CST 2024, time=2024-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2191864, encodeId=ab702191864ab, content=偏重的研究方向:流行病学<br>经验分享:请问显示Peer review是还在编辑手里吗,(Your submission has passed technical checks)<br>另外如果编辑直接拒稿的话也要等1-2个月吗(当然并不希望拒稿T...T), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/efe586ee419a4ea1875eb1b9410dd7cb-vBBeE1cHZ4Jm.jpg, createdBy=3bc48686082, createdName=ms3000001406640384, createdTime=Thu Mar 07 15:50:11 CST 2024, time=2024-03-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1218791, encodeId=3ad61218e9108, content=一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=849, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=78775569128, createdName=ms5000000930127030, createdTime=Wed May 11 17:00:47 CST 2022, time=2022-05-11, status=1, ipAttribution=)]
    2022-05-11 ms5000000930127030

    一审5个月,遇到两个审稿人退稿。二审两个月,遇到初审人没一个同意再审。最终接收。七个多月。好事多磨。

    5

    展开5条回复
共211条页码: 1/22页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分